Using base-editing technology, the pioneering gene therapy (BE-CAR7), has been used to treat a previously untreatable type of ...
Researchers at the University of Geneva, together with colleagues in Switzerland, France, the United States and Israel, ...
Renowned molecular biologist Yunsun Nam, Ph.D., Professor in the Departments of Biochemistry and Biophysics and the Doris and ...
Scientists at UCL and GOSH have used groundbreaking base-edited CAR‑T cell therapy — BE‑CAR7 — to treat aggressive T‑cell ...
Bryan Johnson, the founder of Braintree and subject of a new Netflix doc, is on a quest for remarkable longevity. Inside most (seemingly) outlandish perspectives lie kernels of truth—and sometimes the ...
Press Trust of India on MSN
Miltenyi Biotec receives 'Special Recognition Award' for pioneering work in cell and gene therapy at BioSpectrum India Excellence Awards 2025
NEW DELHI, Dec ...
Leg-spinner Yuzvendra Chahal's maiden six-wicket for India as the hosts beat England by 75 runs in the third and final Twenty20 International ...
The CVCT Forum is an annual, invite-only workshop that aims to cultivate a multi-stakeholder exchange to enhance clinical trials, streamline regulatory approval processes, and facilitate the ...
The first study assessing the real-world commercial roll-out of gene therapies for sickle cell disease and beta thalassemia offers lessons learned to inform best practices as manufacturers and medical ...
Novartis’ Itvisma wins FDA approval as the first gene replacement therapy for spinal muscular atrophy (SMA) patients age 2 ...
Researchers created a highly efficient gene-editing method that fixes multiple DNA mutations in a single step. The breakthrough could revolutionize genetic medicine by making treatments for complex ...
Discover why Cryoport (CYRX) offers deep value for investors as the leader in temperature-controlled logistics for cell and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback